Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aethlon Medical has reported that it will initiate studies to test the in vitro effectiveness of the Aethlon Hemopurifier to capture West Nile virus, an infectious disease.
Subscribe to our email newsletter
The studies are designed to evaluate the potential of the Hemopurifier to treat West Nile virus (WNV), and to further demonstrate the broad-spectrum effectiveness of the Hemopurifier to capture viral pathogens. The WNV studies will be conducted at the Battelle Biomedical Research Center, a global research organization.
Aethlon Medical considers the Hemopurifier to be the leading broad-spectrum candidate as evidenced by its breadth of preclinical data and human treatment experience. Data resulting from the WNV study and other clinical programs will be included in a forthcoming submission to US Department of Health and Human Services (HHS) and the newly established Biomedical Research and Development Authority (BARDA) to advance the commercialization of the Hemopurifier as a broad-spectrum countermeasure against bioterror and pandemic threats.